Grant: CIHR REDI Early Career Transition Award - General
McGill University
$270,000.00
Identifying mechanisms and biomarkers of perinatal depression for improving treatment and risk prediction: A translational approach
FY 2023-24
Summary
One in five pregnant people will experience significant mental health problems during or after pregnancy (the perinatal period), most commonly depression. Perinatal depression often goes undiagnosed or untreated, which can negatively impact both parent and child. Although treatments are available, they do not work well for everyone. More treatment options are needed, along with better ways to predict which treatments will be most effective for each person. Additionally, there are promising interventions that can prevent perinatal depression, but limited resources are available for their implementation. Identifying people at increased risk for perinatal depression is crucial to ensure that those who are most likely to benefit from interventions receive them. However, predicting who is at higher risk for perinatal depression remains difficult. To address these challenges, my research has two broad goals. First, I seek to better understand the underlying brain biology of perinatal depression. Second, I aim to develop new methods for better predicting perinatal depression risk and treatment response. I will use mouse models to study changes in the brain that may occur in perinatal depression, from molecules to communication in brain circuits. This knowledge can help us develop new, effective treatments. To predict risk for perinatal depression, I rely on existing evidence that some people may be more sensitive to the hormonal changes associated with pregnancy, putting them at greater risk for perinatal depression. I developed a new blood test for hormone sensitivity, which I will use to assess risk for perinatal depression. I will also use this blood test to assess whether we can predict response to a new, hormone-based treatment for perinatal depression. Overall, my research aims to improve our understanding of perinatal depression and its treatment and has the potential to tangibly improve health outcomes for both parents and children.
Department
Program
CIHR REDI Early Career Transition Award - General
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
491460
Name
Eid Rand
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
CIHR REDI Early Career Transition Award
Projecttitle
Identifying mechanisms and biomarkers of perinatal depression for improving treatment and risk prediction: A translational approach
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$270,000
Cihrequipment2
$0
Programname2
CIHR REDI Early Career Transition Award - General
Keyworddelim
Biomarker Discovery; Gene Expression; Neural Circuits; Perinatal Depression; Translational Neuroscience
Abstract
One in five pregnant people will experience significant mental health problems during or after pregnancy (the perinatal period), most commonly depression. Perinatal depression often goes undiagnosed or untreated, which can negatively impact both parent and child. Although treatments are available, they do not work well for everyone. More treatment options are needed, along with better ways to predict which treatments will be most effective for each person. Additionally, there are promising interventions that can prevent perinatal depression, but limited resources are available for their implementation. Identifying people at increased risk for perinatal depression is crucial to ensure that those who are most likely to benefit from interventions receive them. However, predicting who is at higher risk for perinatal depression remains difficult. To address these challenges, my research has two broad goals. First, I seek to better understand the underlying brain biology of perinatal depression. Second, I aim to develop new methods for better predicting perinatal depression risk and treatment response. I will use mouse models to study changes in the brain that may occur in perinatal depression, from molecules to communication in brain circuits. This knowledge can help us develop new, effective treatments. To predict risk for perinatal depression, I rely on existing evidence that some people may be more sensitive to the hormonal changes associated with pregnancy, putting them at greater risk for perinatal depression. I developed a new blood test for hormone sensitivity, which I will use to assess risk for perinatal depression. I will also use this blood test to assess whether we can predict response to a new, hormone-based treatment for perinatal depression. Overall, my research aims to improve our understanding of perinatal depression and its treatment and has the potential to tangibly improve health outcomes for both parents and children.
Competitiondate
202305
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Eid, Rand
Approvedterm
3 ans 0 mois
Cihrcontribution2
III~ $270,000~ $0~